Boston Family Office LLC Sells 37,563 Shares of Teradyne, Inc. $TER

Key Points

• Boston Family Office LLC has sold 37,563 shares of Teradyne, Inc., reducing its holdings by 34.8% to a total of 70,384 shares valued at approximately $5.8 million.
• Teradyne reported a 10.7% year-over-year decline in revenue during its latest quarter, though it exceeded earnings expectations with $0.57 per share compared to a consensus estimate of $0.54.
• The company has announced a $1 billion share buyback program, suggesting confidence in its stock valuation, and a majority of its shares (99.77%) are owned by institutional investors.

Boston Family Office LLC lessened its holdings in Teradyne, Inc. (NASDAQ:TER - Free Report) by 34.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 70,384 shares of the company's stock after selling 37,563 shares during the period. Boston Family Office LLC's holdings in Teradyne were worth $5,814,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of TER. Berbice Capital Management LLC lifted its holdings in Teradyne by 200.0% in the first quarter. Berbice Capital Management LLC now owns 300 shares of the company's stock valued at $25,000 after acquiring an additional 200 shares during the last quarter. Strategic Investment Solutions Inc. IL acquired a new position in Teradyne in the fourth quarter valued at approximately $34,000. Manchester Capital Management LLC lifted its holdings in Teradyne by 44.7% in the first quarter. Manchester Capital Management LLC now owns 453 shares of the company's stock valued at $37,000 after acquiring an additional 140 shares during the last quarter. Sentry Investment Management LLC acquired a new position in Teradyne in the first quarter valued at approximately $45,000. Finally, AdvisorNet Financial Inc lifted its holdings in Teradyne by 319.0% in the first quarter. AdvisorNet Financial Inc now owns 595 shares of the company's stock valued at $49,000 after acquiring an additional 453 shares during the last quarter. 99.77% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO Gregory Stephen Smith sold 554 shares of the firm's stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $106.00, for a total value of $58,724.00. Following the sale, the chief executive officer directly owned 96,993 shares in the company, valued at approximately $10,281,258. This trade represents a 0.57% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.16% of the stock is currently owned by corporate insiders.

Teradyne Price Performance

Shares of TER stock traded down $1.45 during trading hours on Wednesday, reaching $109.17. 2,388,284 shares of the company were exchanged, compared to its average volume of 3,486,828. Teradyne, Inc. has a fifty-two week low of $65.77 and a fifty-two week high of $144.16. The stock's fifty day moving average is $96.12 and its two-hundred day moving average is $91.17. The company has a market cap of $17.37 billion, a price-to-earnings ratio of 37.75, a P/E/G ratio of 2.31 and a beta of 1.72.

Teradyne (NASDAQ:TER - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.03. Teradyne had a net margin of 16.59% and a return on equity of 18.16%. The company had revenue of $651.80 million during the quarter, compared to the consensus estimate of $649.02 million. During the same quarter in the prior year, the firm earned $0.86 earnings per share. The firm's revenue was down 10.7% compared to the same quarter last year. Teradyne has set its Q3 2025 guidance at 0.690-0.870 EPS. On average, research analysts anticipate that Teradyne, Inc. will post 3.88 earnings per share for the current year.

Teradyne announced that its Board of Directors has approved a share buyback plan on Monday, April 28th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the company to reacquire up to 8.1% of its stock through open market purchases. Stock buyback plans are generally a sign that the company's management believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Wall Street Zen upgraded Teradyne from a "sell" rating to a "hold" rating in a research note on Saturday. Morgan Stanley upgraded Teradyne from an "underweight" rating to an "equal weight" rating and upped their price target for the stock from $74.00 to $100.00 in a research note on Thursday, July 31st. The Goldman Sachs Group reaffirmed a "sell" rating and set a $85.00 price objective on shares of Teradyne in a research report on Wednesday, July 30th. Susquehanna cut their price objective on Teradyne from $155.00 to $133.00 and set a "positive" rating on the stock in a research report on Wednesday, April 30th. Finally, Cowen reaffirmed a "buy" rating on shares of Teradyne in a research report on Wednesday, July 30th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, five have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $114.44.

About Teradyne

Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.